Suppr超能文献

登革热患儿毛细血管渗漏与 CD8+T 细胞反应时间的关系。

Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue.

机构信息

Oxford University Clinical Research Unit and Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.

出版信息

J Immunol. 2010 Jun 15;184(12):7281-7. doi: 10.4049/jimmunol.0903262. Epub 2010 May 12.

Abstract

Immune activation is a feature of dengue hemorrhagic fever (DHF) and CD8+ T cell responses in particular have been suggested as having a role in the vasculopathy that characterizes this disease. By phenotyping CD8+ T cells (CD38+/HLA-DR+, CD38+/Ki-67+, or HLA-DR+/Ki-67+) in serial blood samples from children with dengue, we found no evidence of increased CD8+ T cell activation prior to the commencement of resolution of viremia or hemoconcentration. Investigations with MHC class I tetramers to detect NS3(133-142)-specific CD8+ T cells in two independent cohorts of children suggested the commencement of hemoconcentration and thrombocytopenia in DHF patients generally begins before the appearance of measurable frequencies of NS3(133-142)-specific CD8+ T cells. The temporal mismatch between the appearance of measurable surface activated or NS3(133-142)-specific CD8+ T cells suggests that these cells are sequestered at sites of infection, have phenotypes not detected by our approach, or that other mechanisms independent of CD8+ T cells are responsible for early triggering of capillary leakage in children with DHF.

摘要

免疫激活是登革出血热(DHF)的一个特征,特别是 CD8+T 细胞反应被认为在血管病变中起作用,这种血管病变是该疾病的特征。通过对登革热患儿的连续血液样本进行 CD8+T 细胞表型分析(CD38+/HLA-DR+、CD38+/Ki-67+或 HLA-DR+/Ki-67+),我们没有发现病毒血症或血细胞比容恢复前 CD8+T 细胞激活增加的证据。用 MHC Ⅰ类四聚体检测两个独立的儿童队列中 NS3(133-142)特异性 CD8+T 细胞的研究表明,DHF 患者的血细胞比容和血小板减少通常在可测量的 NS3(133-142)特异性 CD8+T 细胞出现之前开始。可测量的表面激活或 NS3(133-142)特异性 CD8+T 细胞出现的时间不匹配表明这些细胞被隔离在感染部位,具有我们的方法无法检测到的表型,或者其他独立于 CD8+T 细胞的机制负责引发 DHF 患儿的毛细血管渗漏。

相似文献

1
Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue.
J Immunol. 2010 Jun 15;184(12):7281-7. doi: 10.4049/jimmunol.0903262. Epub 2010 May 12.
3
Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
J Virol. 2016 Nov 28;90(24):11259-11278. doi: 10.1128/JVI.01424-16. Print 2016 Dec 15.
4
T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity.
J Immunol. 2002 Jun 1;168(11):5959-65. doi: 10.4049/jimmunol.168.11.5959.
5
Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.
J Virol. 2013 Mar;87(5):2693-706. doi: 10.1128/JVI.02675-12. Epub 2012 Dec 19.
6
Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
Front Immunol. 2018 Oct 1;9:2225. doi: 10.3389/fimmu.2018.02225. eCollection 2018.
9
Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?
J Infect Dis. 2001 Dec 1;184(11):1369-73. doi: 10.1086/324320. Epub 2001 Nov 13.
10
T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection.
Immunology. 2020 May;160(1):90-102. doi: 10.1111/imm.13185. Epub 2020 Apr 6.

引用本文的文献

2
Dengue and COVID-19: two sides of the same coin.
J Biomed Sci. 2022 Jul 3;29(1):48. doi: 10.1186/s12929-022-00833-y.
3
Single-cell temporal analysis of natural dengue infection reveals skin-homing lymphocyte expansion one day before defervescence.
iScience. 2022 Mar 5;25(4):104034. doi: 10.1016/j.isci.2022.104034. eCollection 2022 Apr 15.
4
Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge?
Front Med Technol. 2021 Apr 12;3:640964. doi: 10.3389/fmedt.2021.640964. eCollection 2021.
5
Generation and characterization of genetically and antigenically diverse infectious clones of dengue virus serotypes 1-4.
Emerg Microbes Infect. 2022 Dec;11(1):227-239. doi: 10.1080/22221751.2021.2021808.
7
Kinetics of CD4 T Helper and CD8 Effector T Cell Responses in Acute Dengue Patients.
Front Immunol. 2020 Sep 24;11:1980. doi: 10.3389/fimmu.2020.01980. eCollection 2020.
9
Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?
Pathogens. 2020 Jun 15;9(6):470. doi: 10.3390/pathogens9060470.
10
Cutaneous Dengue Virus Inoculation Triggers Strong B Cell Reactions but Contrastingly Poor T Cell Responses.
Virol Sin. 2020 Oct;35(5):575-587. doi: 10.1007/s12250-020-00213-6. Epub 2020 Apr 20.

本文引用的文献

1
Understanding the contribution of cellular immunity to dengue disease pathogenesis.
Immunol Rev. 2008 Oct;225:300-13. doi: 10.1111/j.1600-065X.2008.00678.x.
6
Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.
J Infect Dis. 2007 Aug 1;196(3):416-24. doi: 10.1086/519170. Epub 2007 Jun 19.
7
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9422-7. doi: 10.1073/pnas.0703498104. Epub 2007 May 15.
8
Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection.
J Exp Med. 2007 May 14;204(5):979-85. doi: 10.1084/jem.20061381. Epub 2007 Apr 23.
9
Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study.
Pediatr Infect Dis J. 2007 Apr;26(4):283-90; discussion 291-2. doi: 10.1097/01.inf.0000258612.26743.10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验